Patents Assigned to OLINK PROTEOMICS AB
  • Patent number: 12540355
    Abstract: A pool of multiple nucleic acid reporter molecule species are for use in a massively parallel DNA sequencing method. All members of an individual reporter molecule species have identical nucleic acid sequences. The members of each reporter molecule species comprise, in order from 3?-end to 5?-end: (i) a first sequencing adapter, (ii) a first identification (ID) sequence, (iii) a first hybridisation sequence, or a first hybridisation sequence and a second hybridisation sequence, (iv) a second ID sequence, and (v) a second sequencing adapter. The combination of the first ID sequence and the second ID sequence are unique to the members of an individual reporter molecule species. The first hybridisation sequence is or the first hybridisation sequence and the second hybridisation sequence are, respectively, shared between a plurality of different reporter molecule species, and the sequencing adapters are shared between all reporter molecule species.
    Type: Grant
    Filed: April 8, 2025
    Date of Patent: February 3, 2026
    Assignee: OLINK PROTEOMICS AB
    Inventors: John Broberg, Martin Lundberg, Lotta Wik
  • Patent number: 12534751
    Abstract: Products for detecting a plurality of protein analytes comprise a plurality of proximity probe pairs comprising first and second proximity probes having an antibody or antibody fragment specific for the same protein analyte and a nucleic acid domain, which probes can simultaneously bind to the analyte. Each pair is specific for a different analyte. Each nucleic acid domain comprises an ID sequence and at least a first hybridisation sequence. In each probe pair, ID sequences correspond to a particular analyte, and the probes comprise paired hybridisation sequences. For each probe pair, a splint oligonucleotide comprises hybridisation sequences complementary to each of the paired hybridisation sequences. When probes bind to their protein analyte, the respective paired hybridisation sequences can hybridise to the splint oligonucleotide. At least one pair of hybridisation sequences is shared by at least two pairs of proximity probes. A plurality of sample index oligonucleotides is also included.
    Type: Grant
    Filed: April 8, 2025
    Date of Patent: January 27, 2026
    Assignee: OLINK PROTEOMICS AB
    Inventors: John Broberg, Martin Lundberg, Lotta Wik
  • Patent number: 10781473
    Abstract: The present invention provides a plurality of pairs of proximity probes, each pair being capable of binding to a different target analyte, wherein the first and second proximity probes of each pair of probes comprise universal oligonucleotides conjugated to their analyte binding moieties, and hybridised to the universal oligonucleotides are different tag oligonucleotides comprising universal complement domains common to all tag oligonucleotides and unique domains unique to each tag oligonucleotide, as well as methods for their production.
    Type: Grant
    Filed: October 21, 2016
    Date of Patent: September 22, 2020
    Assignee: OLINK PROTEOMICS AB
    Inventors: Johan Erik Simon Fredriksson, Klas Martin Lundberg
  • Patent number: 10731206
    Abstract: The present invention relates to a proximity probe based detection assay (“proximity assay”) for an analyte in a sample, specifically a proximity probe extension assay (PEA), an in particular to an improvement in the method to reduce non-specific “background” signals, wherein the improvement comprises the use in such assays of a component comprising 3? exonuclease activity, said method comprising: (a) contacting said sample with at least one set of at least first and second proximity probes, which probes each comprise an analyte-binding domain and a nucleic acid domain and can simultaneously bind to the analyte; (b) allowing the nucleic acid domains of the proximity probes to interact with each other upon binding of said proximity probes to said analyte, wherein said interaction comprises the formation of a duplex; (c) contacting said sample with a component comprising 3? exonuclease activity; (d) extending the 3? end of at least one nucleic acid domain of said duplex to generate an extension product, wherein
    Type: Grant
    Filed: September 1, 2017
    Date of Patent: August 4, 2020
    Assignee: OLINK PROTEOMICS AB
    Inventors: Simon Fredriksson, Martin Lundberg, Anna Larsson, Emma Rennel-Dickens
  • Patent number: 9902993
    Abstract: The present invention relates to a proximity probe based detection assay (“proximity assay”) for an analyte in a sample, specifically a proximity probe extension assay (PEA), an in particular to an improvement in the method to reduce non-specific “background” signals, wherein the improvement comprises the use in such assays of a hyperthermophilic polymerase, said method comprising: (a) contacting said sample with at least one set of at least first and second proximity probes, which probes each comprise an analyte-binding domain and a nucleic acid domain and can simultaneously bind to the analyte; (b) allowing the nucleic acid domains of the proximity probes to interact with each other upon binding of said proximity probes to said analyte, wherein said interaction comprises the formation of a duplex; (c) extending the 3? end of at least one nucleic acid domain of said duplex to generate an extension product, wherein the extension reaction comprises increasing the temperature of assay above room temperature and
    Type: Grant
    Filed: January 29, 2013
    Date of Patent: February 27, 2018
    Assignee: OLINK PROTEOMICS AB
    Inventors: Simon Fredriksson, Martin Lundberg, Anna Eriksson, Emma Rennel-Dickens
  • Patent number: 9777315
    Abstract: The present invention relates to a proximity probe based detection assay (“proximity assay”) for an analyte in a sample, specifically a proximity probe extension assay (PEA), an in particular to an improvement in the method to reduce non-specific “background” signals, wherein the improvement comprises the use in such assays of a component comprising 3? exonuclease activity, said method comprising: (a) contacting said sample with at least one set of at least first and second proximity probes, which probes each comprise an analyte-binding domain and a nucleic acid domain and can simultaneously bind to the analyte; (b) allowing the nucleic acid domains of the proximity probes to interact with each other upon binding of said proximity probes to said analyte, wherein said interaction comprises the formation of a duplex; (c) contacting said sample with a component comprising 3? exonuclease activity; (d) extending the 3? end of at least one nucleic acid domain of said duplex to generate an extension product, wherein
    Type: Grant
    Filed: January 30, 2012
    Date of Patent: October 3, 2017
    Assignee: OLINK PROTEOMICS AB
    Inventors: Simon Fredriksson, Martin Lundberg, Anna Eriksson, Emma Rennel-Dickens
  • Patent number: 9677131
    Abstract: The present invention relates to the use of a conjugate of a non-analyte-specific binding protein coupled to a nucleic acid as a blocking reagent in a probe-based detection assay, which uses a probe comprising a proteinaceous analyte-binding partner coupled to a nucleic acid domain to detect an analyte in a sample.
    Type: Grant
    Filed: July 13, 2011
    Date of Patent: June 13, 2017
    Assignee: OLINK PROTEOMICS AB
    Inventors: Simon Fredriksson, Bonnie Tran
  • Patent number: D1091599
    Type: Grant
    Filed: December 20, 2022
    Date of Patent: September 2, 2025
    Assignee: Olink Proteomics AB
    Inventor: Ola Caster